| Literature DB >> 36229484 |
Rengul Cetin-Atalay1,2, Angelo Y Meliton1,2, Kaitlyn A Sun1,2, Mariel E Glass1,2, Parker S Woods1,2, Ying-Jie Peng1,3,4, Yun Fang1,2,4, Robert B Hamanaka1,2,4, Nanduri R Prabhakar1,3,4, Gökhan M Mutlu5,6,7.
Abstract
Obstructive sleep apnea (OSA) is an independent risk factor for cardiovascular disease. While intermittent hypoxia (IH) and catecholamine release play an important role in this increased risk, the mechanisms are incompletely understood. We have recently reported that IH causes endothelial cell (EC) activation, an early phenomenon in the development of cardiovascular disease, via IH-induced catecholamine release. Here, we investigated the effects of IH and epinephrine on gene expression in human aortic ECs using RNA-sequencing. We found a significant overlap between IH and epinephrine-induced differentially expressed genes (DEGs) including enrichment in leukocyte migration, cytokine-cytokine receptor interaction, cell adhesion and angiogenesis. Epinephrine caused higher number of DEGs compared to IH. Interestingly, IH when combined with epinephrine had an inhibitory effect on epinephrine-induced gene expression. Combination of IH and epinephrine induced MT1G (Metallothionein 1G), which has been shown to be highly expressed in ECs from parts of aorta (i.e., aortic arch) where atherosclerosis is more likely to occur. In conclusion, epinephrine has a greater effect than IH on EC gene expression in terms of number of genes and their expression level. IH inhibited the epinephrine-induced transcriptional response. Further investigation of the interaction between IH and epinephrine is needed to better understand how OSA causes cardiovascular disease.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36229484 PMCID: PMC9561121 DOI: 10.1038/s41598-022-21614-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Transcriptional changes in human aortic endothelial cells after exposure to intermittent hypoxia. Human Aortic Endothelial Cells (HAECs) were exposed to 60 cycles of IH (5%-20% O2) or normoxia (20% O2) (control). RNA-sequencing was performed from RNA isolated from 3 biological replicates. (a) Multidimensional scaling plot of differentially expressed genes in HAECs under IH compared to control normoxia. LogFC dim 1, and dim 2: base 2 logarithm of fold change dimension 1 and 2. (b) Volcano plot of -Log10 (p values) vs. Log2 fold change for DEGs and top significantly upregulated genes in IH. The -log10 (p values) represents the level of significance of each gene while log2 fold change represents the difference between the levels of expression for each gene. (c) Using qPCR, we measured mRNA expression of E-selectin (SELE), Fatty acid binding protein 4 (FABP4), Cytosolic phospholipase A2 gamma (PLA2G4C), and Hematopoietic progenitor cell antigen CD34 (CD34) in HAECs under control normoxia and IH (data are shown as mean ± SD, n = 6, biologic replicates). *p < 0.05. Parameters for DEG significance were set to absolute fold change ≥ 2 and FDR adjusted p value ≤ 0.05. Activated and suppressed (d) gene ontology biological processes (GO BP) and (e) activated KEGG pathways were identified by gene set enrichment analysis of DEGs in HAECs under IH compared to normoxia. The raw source data for RNA-seq are accessible via GEO (GSE205050). https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE205050.
Figure 2Transcriptional changes in human aortic endothelial cells after treatment with epinephrine. HAECs were treated with epinephrine (10 µM) or vehicle control for 7 h under normoxia (20% O2) using the perfusion system. RNA-sequencing was performed from RNA isolated 3 biological replicates. (a) Multidimensional scaling plot of differentially expressed genes in HAECs treated with epinephrine or vehicle control. LogFC dim 1, and dim 2: base 2 logarithm of fold change dimension 1 and 2. (b) Volcano plot of -Log10 (p values) vs. Log2 fold change for DEGs and top significantly upregulated genes upon epinephrine treatment. The -log10 (p values) represents the level of significance of each gene while log2 fold change represents the difference between the levels of expression for each gene. (c) Using qPCR, we measured mRNA expression of EFNA1, FABP4, PLA2G4C, CD34, Transcription factor jun-B (JUNB), Nuclear receptor subfamily 4 group A member 1 (NR4A1) and Interferon regulatory factor 1 (IRF1) in HAECs under control normoxia and IH (data are shown as mean ± SD, n = 6, biologic replicates). *p < 0.05. Parameters for DEG significance were set to absolute fold change ≥ 2 and FDR adjusted p value ≤ 0.05. Activated and suppressed gene (d) ontology biological processes (GO BP) and (e) activated and suppressed KEGG pathways were identified by gene set enrichment analysis of DEGs in HAECs treated with epinephrine compared to control treatment.
Figure 3Epinephrine induces significantly higher number of DEGs compared to IH in human aortic endothelial cells. Differentially expressed gene profiles of HAECs, which were treated with epinephrine (10 µM) under normoxia or were exposed to 60 cycles of IH (5%-20% O2) perfusion system, were comparatively analyzed. (a) Heatmap of top significantly upregulated genes by IH in normoxia controls and IH- or epinephrine-treated HAECs. Z-score normalized expression values are shown in heat map, scale bar represents logFC values. “Pretty heatmaps R pheatmap package” from Z-score normalized expression values. https://cran.r-project.org/web/packages/pheatmap/pheatmap.pdf (b) Venn diagrams show differentially expressed genes (absolute fold change ≥ 2 and p value ≤ 0.05) in epinephrine-treated normoxic ECs (635 DEGs), and IH-exposed HAECs (184 DEGs). GO biological process (c) and KEGG pathway (d) enrichment analysis of gene set that were common between IH and epinephrine by Enrichr gene set search engine. GO biological process (e) and KEGG pathway (f) enrichment analysis of gene set that were specific to epinephrine by Enrichr gene set search engine.
Figure 4Combining IH with epinephrine significantly alters epinephrine-induced changes in gene expression. HAECs were exposed to 60 cycles of IH (5%-20% O2) in the presence of 10 µM epinephrine and vehicle control. We then isolated RNA from 3 biologic replicates and performed RNA-sequencing. (a) Multidimensional scaling plot and (b) Volcano plots of DEGs in HAECs treated with normoxia + epinephrine and IH + epinephrine. (c) Heat map displaying the expression level of top epinephrine-upregulated genes in HAECs treated with epinephrine or vehicle control under normoxic and IH conditions. “Pretty heatmaps R package pheatmap package” from Z-score normalized expression values. https://cran.r-project.org/web/packages/pheatmap/pheatmap.pdf (d) Using qPCR, we measured mRNA expression of MT1G measured by qPCR in HAECs treated and untreated with 10 µm epinephrine under IH and normoxia (mean ± SD, n = 6, biologic replicates). *p < 0.05. (e) Multidimensional scaling plot of DEGs in HAECs treated with IH in the presence or absence of epinephrine (10 µM). (f) Volcano plot of DEGs in HAECs treated with IH in the presence or absence of epinephrine. Metallothionein-1G (MT1G) is highly differentially upregulated under IH supplemented with 10 µM epinephrine. (g) We also measured mRNA expression of epinephrine-upregulated genes, JUNB, EFNA1, IRF1, and NR4A1 in HAECs treated with epinephrine or vehicle control under normoxic and IH conditions (mean ± SD, n = 6, biologic replicates). *p < 0.05.